Iridex Corp
IRIX- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001006045
In the last 90 days, Iridex Corp insiders filed 4 open-market purchases and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.47M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Iridex Corp changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 20 | 22 | +2 |
| Shares | 2.69M | 2.83M | +145.0K (+5.4%) |
| Value | $2.37M | $3.24M | +$870.8K (+36.7%) |
New holders (4)
Institutions that held Iridex Corp at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 47,793 | $54.5K | 0.00% |
| Centiva Capital, LP | 18,768 | $21.6K | 0.00% |
| Jane Street Group, LLC | 16,381 | $18.7K | 0.00% |
| Simplex Trading, LLC | 759 | $0 | 0.00% |
Sold out (2)
Institutions that held Iridex Corp at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Thompson Davis & Co., Inc. | 56,726 | $50.0K |
| Raymond James Financial Inc | 700 | $617 |